Clinical Trial Update: 12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine [Phase 3]

View source ↗

Summary

Phase 3 trial of atogepant for preventive treatment of episodic migraine has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Episodic Migraine

Drugs mentioned

• Atogepant (Atogepant)

Snippet

Sponsor: Allergan | Conditions: Episodic Migraine | Phase 3 | Status: COMPLETED | Results posted: 2021-07-09